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Abstract: Type 1 diabetes (Dm1) is a chronic endocrine and metabolic disease that affects the whole 
person and requires active, decisive treatment. However, personality traits may influence a patient’s 
adherence to treatment guidelines. The objective of this work is firstly to identify the 3 Asendorpf 
personality prototypes (resilient, undercontrolled and overcontrolled) in a sample of Dm1 individ-
uals and determine whether there are any differences in comparison with a control sample; and, 
secondly, to study their association with adherence to self-care guidelines using both physiological 
indicators (HbA1C) and self-report measures. To achieve these objectives, a descriptive cross-sec-
tional study was carried out. The sample comprised 294 participants, of whom 104 were people with 
Dm1 and 190 were controls. The participants, aged between 14 and 34 years, were classified by their 
scores in NEO-FFI-R, according to the personality characteristics inherent to Asendorpf’s proto-
types. Asendorpf’s 3 prototypical personality patterns were found both in the group of people with 
Dm1 and in the control sample. These patterns showed different degrees of association with adher-
ence to self-care guidelines for this disease and with psychological health factors. Importance 
should therefore be attached to the personality traits and Asendorpf prototypes of people with Dm1 
when proposing interventions to address medical, psychological, and behavioral aspects. 
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1. Introduction 
Type 1 Diabetes (Dm1) is a chronic metabolic condition caused by an absolute insulin 
deficiency [1] brought about by the autoimmune destruction of pancreatic β-cells. Treat-
ment includes behavioral and metabolic self-care measures [2] like proper nutrition, 
avoidance of toxic habits such as tobacco and alcohol consumption, and regular physical 
exercise [3]. It also includes insulin administration, self-monitoring of blood glucose, and 
the detection and treatment of hypoglycemia [4]. Dm1 requires a continuum of care with 
coordinated multifactorial strategies aimed at obtaining adequate health outcomes and 
addressing such aspects as patient empowerment and education, psychosocial counsel-
ing, and the taking into account of community aspects that influence lifestyles, among 
other things [2]. 
The diagnosis of Dm1 has a significant impact on the individual, since the prognosis, 
the medium and long-term complications and the characteristics of the treatment make 
the patient’s participation indispensable [4] (up to 95% of the disease management re-
sponsibilities fall on the patient [5]). Some aspects of Dm1, like its unexpected onset at a 
young age, the danger of hyper- and hypoglycemia (excessively high or low glucose lev-
els), the complications that may arise (retinopathy, nephropathy, neuropathy...), and the 
burden of self-care that it entails [6], are justifiably stressful in emotional terms. Adher-
ence to self-care guidelines, defined as a person’s active, voluntary behavior aimed at 
improving, maintaining, and preventing health deterioration, is therefore essential and 
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decisive in Dm1 outcomes [7]. The main dimensions of adherence can be said to be the 
patient’s own behavior and their perception of burden or benefit [8]. This is an important 
aspect to be take into account, because inadequate adherence may result in long-term Dm1 
complications [5]. 
According to some studies [6], Dm1 receives special consideration in the field of 
health psychology [9] precisely because it is so highly demanding, both psychologically 
and behaviorally [5]. In this regard, psychological factors would appear to play an im-
portant role in Dm1 therapy, since this is an illness that affects people’s lifestyles at early 
ages. Dm1 requires continuous, complex treatment with no immediate consequences, and 
self-control over personal behavior is crucial in order to avoid its negative long term ef-
fects and optimize prognosis [9]. 
The role of personality factors has been studied as one of the psychological aspects 
of this disease [10], and much evidence can be found in the scientific literature regarding 
their influence on self-care and Dm1 outcomes. In general, personality traits influence 
health- and illness-related behaviors and are associated with physical health [11–14]. 
Some studies have also specifically indicated the influence of psychological factors, both 
emotional and behavioral, in Dm1, highlighting the very important role they play in ad-
herence to treatment [6,10,15]. 
In this regard, theoretical models like the Type A Personality Pattern (impatience, 
competitiveness) and the Type D Personality Pattern (negative affectivity and social inhi-
bition) have been linked with major health issues such as cardiovascular problems [16,17] 
and low adherence to treatment in Dm2 [18]. Nevertheless, it seems that here Costa and 
McCrae’s Big Five Model [19] may be particularly relevant since it considers a large num-
ber of personality factors and aspects. Indeed, it has been found that each trait plays a role 
in glycemic control [20] and therefore has a different impact on adaptation, quality of life, 
and perception of physical and psychological health [21]. Specifically, high Conscientious-
ness and Agreeableness positively influence glycemic control [20], while low Extroversion 
and high Openness are associated with adequate personal control [21]. On the other hand, 
Extraversion and Agreeableness correlate with adherence; and Conscientiousness is re-
lated to adherence and health maintenance [7]. Traits that negatively influence adherence 
are a low level of Conscientiousness and high levels of Extraversion [22] and Neuroticism 
[23]. High Neuroticism and low Conscientiousness are related to negative long-term con-
sequences of the disease [21]. 
Based on these five traits, Asendorpf et al. [24], established that the different patterns 
of personality description are organized into three prototypic patterns, each with their 
own characteristics: resilient, overcontrolled and undercontrolled. The resilient type is 
characterized by a reduced level of Neuroticism and a high level of Conscientiousness. It 
presents flexible responses to changing and stressful situations, which favors good adjust-
ment. The overcontrolled type is related to low Extraversion and high Neuroticism. This 
type presents poor adjustment and tendencies towards feelings of inhibition, shyness, low 
self-esteem, or loneliness. The undercontrolled type is related to low Conscientiousness 
and low Agreeableness. It presents poor adjustment and tendencies to social problems 
such as lack of self-esteem or antisocial behaviors [24]. The influence of these prototypes 
on different physical and psychological health problems has been studied. Specifically, 
their impact has been assessed on subjective health perception [25] and on cardiovascular 
health outcomes [26]. They have been considered as indicators of adaptation and psycho-
social adjustment in adolescents [27] and also as predictors of behavioral problems in chil-
dren and adolescents [28]. Moreover, they have been related to increased risk of eating 
disorders [29] and have been used to estimate admission to a rehabilitation program for 
patients with spinal cord injuries [30]. 
Given that adherence to self-care guidelines is key to optimizing the progression of 
Dm1 and avoiding complications derived from it [7], and considering the influence of 
personality on the perception of and ability to cope with situations in general [12] and 
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with Dm1 in particular [31], it is clearly relevant to take into account the personality char-
acteristics of a person with Dm1 when dealing with the problem of adherence to self-care 
guidelines for such a demanding illness. Bearing in mind that the Asendorpf prototypes 
have predicted individuals’ perception of health and risk of presenting different psycho-
logical problems/psychosocial adjustments and their implications, and that those same 
prototypes have been useful in assessing the effectiveness of rehabilitation interventions, 
the purpose of this work is therefore to describe the personality characteristics of a group 
of people with Dm1, to establish whether the three Asendorpf prototypes are present, and 
to determine whether the Dm1 sample differs from a control sample of people without 
Dm1. These questions have not been addressed in the scientific literature. This paper also 
assesses the relationship between the Asendorpf prototypes and psychological health fac-
tors and other metabolic and behavioral self-care aspects of Dm1. Here, self-care aspects 
mainly refer to the monitoring of glucose levels, insulin administration, glycosylated he-
moglobin (HbA1C) levels and compliance with certain behavioral guidelines (control of 
toxic habits, frequent physical exercise, suitable diet). 
In summary, the objectives of this study are, firstly, to try to identify the three Asen-
dorpf personality prototypes in a sample of people with Dm1 and determine whether 
there are differences with respect to a control sample; and, secondly, to study their asso-
ciation with adherence to self-care guidelines using physiological indicators (HbA1C), 
self-report measures, and psychological health variables. We hypothesize that the three 
Asendorpf prototypes of personality will be found and that people with resilient person-
alities will show emotional stability and, probably, adequate adherence. We also expect 
people with undercontrolled and overcontrolled personality prototypes to present greater 
emotional instability (associated with social and behavioral problems, respectively) and 
worse adherence to self-care guidelines [29]. 
2. Materials and Methods 
2.1. Participants 
This was a descriptive cross-sectional study. The sample comprised 294 Spanish par-
ticipants: a total of 104 people diagnosed with Dm1 and a control group of 190. All partic-
ipants had medium or medium-high levels of education. Regarding sex, 45.60% were men 
and 54.40% were women (X2 = 3.463, p = 0.063). The age of the participants was between 
14 and 34 years, 47.60% of them being ≤ 21(19.20 ± 2.04 years) and 52.40% of them being 
older than 22 (25.82 ± 4.11) (X2 = 3.377, p = 0.066). 
2.2. Instruments 
The information was collected by a paper and pencil survey comprising a general 
anamnesis and several questionnaires. The anamnesis collected data on age and sex; an-
thropometric characteristics [height (m) and weight (kg)] for the subsequent calculation 
of the Body Mass Index (BMI) (kg/m2); and aspects related to behavioral habits (consump-
tion of alcohol (number of SDUs) and tobacco (number of cigarettes), physical exercise 
(frequency per week) and estimation of diet adherence (deficient/regular/adequate)). In 
addition, the following Dm1-related data were collected: HbA1c levels, times of glucose 
monitoring, times of insulin administration, years with Dm1 diagnosis and estimation of 
knowledge about Dm1 (Good/Normal/Poor). Glucose levels are monitored by means of a 
self-applied technique based on using different devices (glucometers) to determine the 
current levels of glucose in a person’s blood. This is necessary because food, medication, 
physical exercise, and stress affect the blood sugar level, and it is essential to know this 
level before administering the appropriate dose of insulin. People with Dm1 are educated 
to determine the appropriate dosage and self-administer it through diabetes education 
services provided mainly by health services. 
The questionnaires used were as follows: for personality traits, the NEO-FFI-R (ab-
breviated version of the NEO-PI-R) was used, consisting of 60 items with five response 
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options. This questionnaire assesses the five major personality traits: Neuroticism (N), Ex-
traversion (E), Openness to Experience (O), Agreeableness (A) and Conscientiousness (C) 
[19]. It has adequate test-retest reliability, good stability coefficients (0.68–0.83), and good 
convergent validity indices, which correlate with analogous constructs [16]. 
The Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) ques-
tionnaire was used for psychological health factors. CORE-OM has 34 items with five re-
sponse options [32], grouped into four scales: subjective distress (W) (four items), daily 
functioning (F) (12 items), problems/symptoms (P) (12 items) and risk (R) (six items). In 
turn, each scale has several subscales. The P scale comprises four subscales, which assess 
anxiety problems/symptoms (four items), depression problems/symptoms (four items), 
physical symptoms (two items) and trauma (two items). The F scale comprises three sub-
scales, assessing level of functioning (four items), social relationships (four items) and in-
timate relationships (four items). The R scale comprises two subscales, assessing self-harm 
(four items) and harm to others (two items). CORE-OM also provides a total score, group-
ing together the W, P and F scales; and another total score that includes all four scales (W, 
P, F and R). These totals indicate the general emotional state of the subject. This question-
naire has high internal consistency (Cronbach’s α 0.75–0.90 for all dimensions) and high 
test-retest correlation (0.87–0.91). 
The information collection dossier also included an information sheet on the study, 
requesting the collaboration and informed consent of the participants. The dossier for the 
control group was the same as that of the case sample, except for the absence of data re-
lated to the disease. 
2.3. Procedure 
The research project was presented to the Research Ethics Committee of the Anda-
lusian Regional Government Health Services and obtained a favorable report (Act No. 
259, ref. 3292,1-16-2017). 
The sample was obtained from a clinical context, namely one of the Endocrinology 
outpatient clinics of the Reina Sofía University Hospital in Cordoba. Participants were 
asked to take part in the study with the collaboration of the clinic staff, endocrinologists, 
and nurses. They were given the information collection dossier, which they completed 
and then returned to the same office. The control sample was drawn mainly from an aca-
demic context and was made up of people who met the stipulated requirements: i.e., they 
had to be between 14 and 34 years of age and not to have been diagnosed with Dm1. 
Once the dossiers had been collected and the different questionnaires corrected, a 
database was created for subsequent statistical analysis. 
2.4. Statistical Analyses 
First, a descriptive analysis was performed to obtain the mean ± standard deviation 
of the variables analyzed; likewise, the percentages of the options in the dichotomous var-
iables were also calculated. 
For the adherence variable in Dm1, actual adherence and perceived adherence were 
measured. Actual adherence was based on HbA1C levels, a physiological reference pa-
rameter for correct self-care [33]. Values were differentiated according to whether they 
were ≥7%, which is indicative of poor metabolic control of Dm1, or <7%, which would 
indicate good metabolic control of the disease. Perceived adherence would be formed by 
the participants’ self-reported data about their tobacco and alcohol consumption, adher-
ence to a suitable diet, and frequency of physical exercise. The difference between the 
scores of these variables (actual adherence-perceived adherence) was taken as the adher-
ence estimation error, thus differentiating between those who overestimated adherence (re-
porting adequate adherence behavior patterns, when the physiological value indicated 
the opposite), those who underestimated their adherence (having physiological values in-
dicative of good management but reporting worse self-care patterns), and those whose 
perception of their self-care patterns was adequate. The direct scores of the five scales in 
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the NEO-FFI-R questionnaire were transformed into centile scores to group them accord-
ing to Asendorpf’s criteria [21], thus forming three groups. The resilient group included 
subjects with Neuroticism scores <40 and Conscientiousness (C) scores >60. The overcon-
trolled group included subjects with Neuroticism scores > 60 and Extraversion scores <40. 
The undercontrolled group included subjects with Agreeableness scores <40 and Consci-
entiousness scores <40. 
Finally, the differences between prototypes in aspects related to Dm1 and psycholog-
ical health factors were evaluated using the chi-square test (X2) and analysis of variance 
(ANOVA) for qualitative and quantitative variables, respectively. The relationship be-
tween prototypes and psychological health factors was also assessed, both in the case 
group and in the control group, in order to check the differences that may exist in the 
relationships between personality tendencies and psychological factors. 
3. Results 
The different Asendorpf prototypic patterns appeared in both the group of people 
with Dm1 and the control group, but no significant differences were found between the 
two groups (X2 = 6.268, p = 0.099). The percentages are shown in Table 1. 
Table 1. Prototype percentages in Dm1 and Control samples. 
Group Not Classified (%) Resilient (%) Overcontrolled (%) Undercontrolled (%) 
Dm1 51.90 24.00 6.70 17.30 
Control 50.00 14.70 12.10 23.20 
X2 = 6.268, p = 0.099. 
With respect to actual adherence, measured by HbA1c, no significant differences 
were found in the ANOVA between the three prototypic personality patterns. There were 
differences, however, in perceived adherence (F = 3.664, p = 0.033), with resilient person-
ality types presenting greater perceived adherence: that is to say, they were the ones who 
reported having adequate habits (no excessive consumption of alcohol or tobacco), fol-
lowing a correct diet, and taking frequent physical exercise. 
As indicated in the analysis section, a new variable called adherence estimation error 
was calculated, comparing the results of perceived adherence with those of actual adher-
ence (i.e., the HbA1C value, which is an indicator of the existence of poor or good meta-
bolic control). The ANOVA showed significant differences (F = 4.985, p = 0.012) between 
prototypes, with resilient personality types making more errors in estimating their adher-
ence. It was also the resilient types that reported a greater amount of diabetes education 
received (F = 12.224, p = 0.002). On the other hand, it was the overcontrolled personality 
types that made the fewest errors in their estimation of adherence, with lower HbA1C 
levels than the resilient types, and which reported not having received diabetes education. 
These data are shown in Table 2. 
Table 2. Adherence data. 
Adherence Data Resilient Overcontrolled Undercontrolled F p ŋ2 
HbA1c 7.62 ± 1.16 6.68 ± 1.43 7.25 ± 0.98 1.484 0.240  
Perceived Adhe-
rence 
0.99 ± 0.90 1.61 ± 0.87 1.74 ± 0.97 3.664 0.033 0.137 
Estimation error 1.70 ± 1.45 −0.32 ± 1.74 0.42 ± 1.54 4.985 0.012 0.222 
HbA1C = Glycosylated hemoglobin. 
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Regarding psychological health factors (measured by the CORE-OM questionnaire), 
the results indicated that there are significant differences between prototypes in some 
scales, both in the group of people with Dm1 and in the control group. The values for the 
different scales (mean ± standard deviation) are shown in Table 3. 
Table 3. CORE-OM questionnaire scores by Asendorpf personality prototype patterns. 
Scale Group Resilient Overcontrolled Undercontrolled F p ŋ2 
Total CORE Dm 1.12 ± 0.25 1.73 ± 0.80 1.36 ± 0.44 5.227 0.009 0.196 
 C 1.28 ± 0.36 1.58 ± 0.41 1.41 ± 0.39 4.053 0.021 0.082 
CORE W Dm 1.93 ± 0.34 2.46 ± 0.83 1.88 ± 0.77 2.545 0.090 0.102 
 C 2.21 ± 0.67 1.90 ± 0.52 2.07 ± 0.64 1.496 0.230  
CORE P Dm 0.73 ± 0.49 1.68 ± 0.86 1.24 ± 0.70 7.354 0.002 0.246 
 C 0.92 ± 0.54 1.82 ± 0.73 1.21 ± 0.69 12.095 0.000 0.210 
CORE PAnxiety  Dm 0.92 ± 0.69 1.71 ± 0.88 1.32 ± 0.79 3.508 0.038 0.135 
 C 0.90 ± 0.59 1.87 ± 0.71 1.31 ± 0.83 10.972 0.000 0.194 
CORE PDepressed Dm 0.47 ± 0.57 1.64 ± 0.96 0.99 ± 0.62 9.628 0.000 0.300 
 C 0.73 ± 0.55 1.76 ± 1.08 1.01 ± 0.70 11.864 0.000 0.207 
CORE PTrauma Dm 1.00 ± 0.77 2.00 ± 0.82 1.59 ± 1.15 3.998 0.025 0.151 
 C 1.38 ± 1.04 1.85 ± 0.79 1.42 ± 0.96 1.951 0.148  
CORE PP.S. Dm 0.63 ± 0.61 1.36 ± 1.07 1.12 ± 0.91 3.194 0.050 0.124 
 C 0.89 ± 0.79 1.80 ± 0.91 1.16 ± 0.99 6.567 0.002 0.126 
CORE F Dm 1.84 ± 0.32 2.04 ± 0.51 1.72 ± 0.55 1.267 0.292  
 C 1.94 ± 0.42 1.87 ± 0.34 1.90 ± 0.29 0.249 0.780 0.005 
CORE FClose Dm 3.11 ± 0.59 2.39 ± 0.67 2.62 ± 0.54 5.925 0.005 0.208 
 C 2.95 ± 0.84 2.16 ± 0.60 2.65 ± 0.69 9.600 0.001 0.143 
CORE FSocial Dm 2.04 ± 0.48 2.50 ± 0.75 1.94 ± 0.67 2.275 0.114  
 C 2.05 ± 0.50 2.16 ± 0.51 2.04 ± 0.39 0.575 0.564  
CORE FGeneral Dm 0.40 ± 0.44 1.21 ± 0.57 0.87 ± 0.68 7.389 0.002 0.247 
 C 0.68 ± 0.62 1.28 ± 0.73 1.01 ± 0.66 5.293 0.007 0.104 
CORE R Dm 0.02 ± 0.07 0.76 ± 1.05 0.36 ± 0.49 7.042 0.002 0.238 
 C 0.11 ± 0.22 0.34 ± 0.42 0.40 ± 0.61 3.284 0.042 0.067 
CORE RSelf. Dm 0.02 ± 0.10 0.79 ± 1.07 0.19 ± 0.50 6.422 0.004 0.222 
 C 0.03 ± 0.10 0.35 ± 0.59 0.30 ± 0.59 3.381 0.038 0.069 
CORE ROthers Dm 0.02 ± 0.10 0.71 ± 1.07 0.71 ± 0.61 9.670 0.000 0.301 
 C 0.25 ± 0.57 0.30 ± 0.39 0.62 ± 0.82 3.139 0.048 0.065 
HbA1C = Glycosylated hemoglobin; Dm = Diabetes; C=Control; W = Subjective well-being; P = Psychological Problems; F 
= Functioning; R = Risk; P.S. = Physical symptoms; R. Self = Risk to self-harm; R. Others = Risk to harm to others; ŋ2 = 
Magnitude of the ANOVA effect. 
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With respect to psychological health factors, overcontrolled personality types pre-
sented higher scores in psychological problems or discomfort, while resilient types pre-
sented the lowest scores (Total CORE [F = 5.227, p = 0.009]). This pattern of resilient (high-
est scores) and overcontrolled (lowest scores) was repeated in the control sample (Total 
CORE [F = 4.053, p = 0.021]). 
With respect to problems and symptoms, both in the CORE P scale and in the other 
subscales, the overcontrolled types had the highest scores, and the resilient types the low-
est scores (CORE P [F = 7.354, p = 0.002]; CORE P Anxiety [F = 3.508, p = 0.038]; CORE P Depressed 
[F = 9.628, p = 0.000]; CORE Trauma [F = 3.998, p = 0.025]; CORE P Physical Symptoms [F = 3.194, p = 
0.050]). In the control group we found the same pattern in the general scale and in the 
anxiety and depression subscales (CORE P [F = 12.095, p = 0.000]; CORE P Anxiety [F = 10.972, 
p = 0.000]); CORE P Depressed [F = 11.864, p = 0.000]). There were no significant differences 
between prototypes in the CORE P Trauma subscale. In the CORE P Physical Symptoms subscale, the 
undercontrolled personality types had the highest scores and the resilient types had the 
lowest scores (F = 6.567, p = 0.002). 
Regarding daily functioning (CORE F), an opposite pattern was observed in relation 
to the intimate relationships (CORE F Close) and functioning level (CORE F General) scales. 
Resilient personality types scored the highest in problems with intimate relationships, and 
overcontrolled types scored the lowest (CORE F Close (F = 5.925, p = 0.005). In daily func-
tioning, however, the overcontrolled types had the highest level of problems and the re-
silient types had the lowest (CORE F General (F = 7.389, p = 0.002). This pattern was repeated 
in the control group in both the CORE F Close (F = 7.600, p = 0.001) and CORE FGeneral (F = 
5.293, p = 0.007) scales. 
Regarding the risk scale, overcontrolled personality types hade the highest scores in 
all three scales: general (CORE R (F = 7.042, p = 0.002)), self-harm (CORE R Self (F = 6.422, p 
= 0.004)), and aggression to others (CORE R Others (F = 9.670, p = 0.000)); while resilient types 
had the lowest scores. The same pattern was seen in the control group as in the people 
with Dm1, (F = 3.381, p = 0.038), with overcontrolled types scoring higher and resilient 
types scoring lower. In the CORE R scale and the CORE R Others subscale, it was the un-
dercontrolled types that scored higher and the resilient types that scored lower (CORE R 
(F = 3.284, p = 0.042) and CORE R Others (F = 3.319, p = 0.048)). 
4. Discussion 
In accordance with the first aim of this study, we identified the three prototypical 
Asendorpf personality patterns in a sample of people with Dm1 and in a control sample. 
These patterns showed different degrees of association with adherence to self-care guide-
lines for Dm1 and with psychological health factors, once again confirming the existence 
of these personality patterns that are differentially related to psychological phenomena 
[24,29] 
According to the results obtained in the present study, there are incongruences be-
tween actual adherence (HbA1C levels) and estimated adherence (self-reported self-care 
behaviors) in people with Dm1. These findings suggest a need to monitor adherence to 
self-care behaviors at a level beyond the individual’s perception [3]. People with Dm1 
evidently make errors when estimating their adherence, with significant differences being 
observed between Asendorpf personality prototypes. The patient’s perception of adher-
ence includes elements like attitudes, perception of benefit or burden of treatment, appre-
ciation, and commitment [8], aspects that involve individual differences consistent with 
the differences we obtained with regard to personality traits. 
Resilient people make more errors in estimating adherence: they report good per-
ceived adherence that is not in accordance with the elevated HbA1C levels they actually 
have, thus, showing overconfidence. This kind of perception error is congruent with the 
good adjustment usually shown by resilient people, because personality influences how 
people perceive and cope with stressful situations [28], and high HbA1C levels are mostly 
not related to emotional distress [34]. Some studies, however, indicate a low interaction 
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between adherence levels and personality styles [35], and link traits associated with the 
resilient prototype (low neuroticism and high conscientiousness [24]) to adequate adap-
tation and adherence [12,21,22]. Ultimately, resilient people with Dm1 may exhibit ade-
quate adaptation, but not adequate adherence, suggesting a positive self-presentation 
bias. This is also compatible with social desirability, a feature which, as suggested in the 
literature [36], may be associated with resilient personality. 
On the other hand, it is the overcontrolled personality types that make the fewest 
errors in the estimation of their adherence and show lower levels of HbA1C—a physio-
logical indicator of correct self-management. However, this adequate metabolic state of 
Dm1 does not translate into psychological well-being, since those same personality types 
are the ones that present more emotional, daily functioning and risk problems. The char-
acteristics of this prototype, high neuroticism and low extroversion [24], can be related to 
beliefs about Dm1 control and perceived consequences which lead to low emotional self-
esteem [37]. 
It seems clear that personality factors have an influence on how people cope with and 
adapt to the Dm1 situation [21]. According to the American Diabetes Association, effective 
behavioral management and adequate psychological self-esteem are fundamental to 
achieve treatment goals [1]. And indeed, individuals in the sample evaluated in this study, 
belonging to different prototypes, were affected differently by psychological health fac-
tors. In general, overcontrolled types were related to a higher level of problems or emo-
tional distress and risk, while resilient types showed the least problems in this area. This 
pattern was repeated in the control sample. 
Diabetes is a challenging situation which impacts a person’s lifestyle and requires 
adaptation to self-care demands [31]. More specifically, having diabetes has been associ-
ated with an increased level of anxiety or distress [31] and an increased risk of depression 
[38]. But although overcontrollers may be associated with higher levels of anxiety and/or 
depression problems [24], our results suggest that personality type does not have a nega-
tive impact on adherence, as indicated in other studies [34,37,39]. On the other hand, re-
silient people scored the lowest in emotional problems and/or symptoms. This coincides 
with the fact that resilience influences the number, intensity, and duration of stress symp-
toms [40]. Although we found that resilient people had the highest HbA1C levels, this ran 
contrary to studies indicating that elevated HbA1C levels are related to anxiety [41] and 
psychological stress [42,43], although other studies have also indicated that elevated 
HbA1C levels are mostly not related to the presence of stress [34]. 
Regarding daily functioning, an important aspect due to the influence of Dm1 on 
lifestyle, resilient people were the least affected in their level of daily functioning but they 
presented more problems in the area of functioning in close relationships, i.e., they 
showed a tendency to feel loneliness and lack of support and affection. This is probably 
explained by social desirability in the answers to the questionnaires, as has been observed 
in a study into the resilient prototype [36]. This condition, together with high critical 
awareness, is associated with the high Conscientiousness scores [19] typical of the resilient 
prototype, and may bring about a greater sense of loneliness, isolation, or lack of support 
[32]—aspects that are included in the functioning in intimate relationships subscale of the 
CORE-OM. These results were repeated in the control participants, and this may be indic-
ative of the presence of a response style in resilient individuals [36]. On the other hand, it 
was the overcontrolled personality type that reported fewer problems in functioning in 
close relationships, although this type also showed greater problems at the level of daily 
functioning, mediated by emotional problems and feelings of inhibition and shyness [24]. 
Thus, although Dm1 does not increase the risk of psychosocial problems [44], social sup-
port favors health outcomes, is a buffer for stressful events, and is related to greater ad-
justment to illness [45]. 
Finally, with respect to risk dimension, overcontrolled people were the ones who 
scored highest in this area, both in self-harm and aggression to others. This may be related 
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to characteristics of this prototype such as low social self-esteem, lower friendship con-
tacts or inhibition and shyness [24]. In general, Dm1 is associated with a higher presence 
of suicidal ideation [46]; and suicidal thoughts have been related to non-adherence to 
treatment [47]. However, this does not coincide with our results, since the overcontrolled 
people in this study presented adequate adherence, as evidenced by low HbA1C levels. 
Nevertheless, there may be an interaction between physical and psychosocial factors af-
fecting quality of life and this can probably lead to problems of adjustment to illness in 
overcontrolled people with Dm1 [6]. This group obtained the worst scores in physical 
symptoms and the other subscales of psychological problems. On the other hand, the re-
silient prototype seemed to be indicative of good adjustment, as resilient people scored 
the lowest in this dimension. 
It would be interesting to be consider the variables studied in this paper in order to 
improve adherence to self-care guidelines and prevent poor evolution of Dm1. Many 
studies indicate that therapeutic protocols for this disease should include physical, psy-
chological, and social aspects [48], and that behavioral interventions could promote med-
ical and psychological outcomes in Dm1 [15]. Interventions for psychological problems 
like depression can improve adherence [49]. An early assessment of psychological comor-
bidity and psychosocial counseling would therefore be desirable to prevent problems and 
improve Dm1 evolution. This is supported by data indicating that decreases in adherence 
to treatment could reflect problems in decision making and executive function [50]; that 
intervention in psychological problems such as depression improves health outcomes in 
Dm1 [51] and adherence [49]; and that multicomponent interventions and operant proce-
dures would probably be effective in improving adherence, with the cognitive-behavioral 
strategy looking particularly promising [52]. 
However, all these issues must be considered with caution. Our work is a cross-sec-
tional study. It would be necessary to assess longitudinally whether changes occur in 
these personality traits over the years of diagnosis and therefore whether such traits have 
any other type of influence on adherence. Our sample of cases was made up of a small 
number of participants, so the number of people belonging to each prototype was also 
small. Furthermore, the questionnaires used were self-reported, and there may have been 
biases in the responses, which could have been influenced by different factors (time to 
answer, context of completion, emotional state in the context of a medical check-up...). 
5. Conclusions 
The different Asendorpf prototypes appear in people with Dm1 and have been 
shown to relate to aspects of adherence to self-care guidelines. Resilient individuals with 
objective data showing poor self-management (high HbA1C levels) are those with the 
greatest error in adherence estimation, while overcontrolled types with HbA1C levels in-
dicative of adequate metabolic control are those with the lowest error in adherence esti-
mation. With respect to psychological health factors, the resilient prototype is associated 
with good adjustment, with fewer emotional problems and with less risk, whereas 
overcontrolled personalities are more affected by emotional problems, daily functioning, 
and risk. 
It would be important to consider the personality traits and the Asendorpf proto-
types of people with Dm1 in order to propose interventions that take into account medical, 
psychological, and behavioral aspects, because this could tell us in advance who would 
be more compliant with self-care recommendations (overcontrolled personalities) and 
who would be more optimistic in their estimation of their adherence, both of which factors 
could later influence Dm1 outcomes and prognoses. 
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